Delivery Order 36F79720D0099-36C24525N0789
Award Date
7/8/25
Potential Completion Date
7/11/25
Potential Value
$13K
Federal Agency
Veterans Integrated Service Network 5
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15275, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer, for the provision of the drug Jynarque (tolvaptan) to VA medical facilities across the Veterans Integrated Service Network 5 region. The $12,559.90 contract is funded through the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract held by Otsuka, which...
This is a $12,580.72 firm-fixed price delivery order awarded by the Department of Veterans Affairs (VA) to Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer, for the supply of the drug Jynarque (tolvaptan). The order is placed under Otsuka's $396 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) with the VA, which enables the efficient procurement of Otsuka's commercial drug products to support healthcare services and treatments...
This is a firm-fixed price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Otsuka America Pharmaceutical Inc., a large pharmaceutical manufacturer, to supply the drug Jynarque (tolvaptan) in dosages of 90mg/30mg. The contract is valued at $13,168.39 and has an ultimate completion date of March 7, 2025. This delivery order is issued under Otsuka's $396 million Federal Supply Schedule contract for pharmaceuticals and hematology-related products with the VA, as well as a...
This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer, for the provision of the drug Jynarque (tolvaptan). The contract has a potential value of $12,580.72 and is a firm-fixed price delivery order under Otsuka's $396 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which allows for the delivery of Jynarque and other...
This is a federal delivery order awarded by the Department of Veterans Affairs (VA) to Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer and supplier. The $13,168.39 firm-fixed price contract is for the drug Jynarque (tolvaptan) in the 90mg/30mg dosage. This delivery order is part of a larger $15 million Blanket Purchase Agreement (BPA) specifically for Jynarque, as well as a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology-related...
This is a firm-fixed price delivery order issued by the Department of Veterans Affairs (VA) to Otsuka America Pharmaceutical Inc., a pharmaceutical manufacturer, for the supply of the drug Jynarque (tolvaptan). The $12,559.90 award is made under Otsuka's $396 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which enables the VA's nationwide healthcare networks to efficiently procure Otsuka's commercial drug offerings, including Jynarque for the...
This is a federal contract award to Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer, to supply the drug Jynarque (tolvaptan) to the U.S. Department of Veterans Affairs (VA). The contract has a ceiling value of $12,580.72 and was awarded on September 20, 2024 as a delivery order under Otsuka's existing Federal Supply Schedule (FSS) contract with the VA. The FSS contract, which has a ceiling value of $396 million, allows the VA to efficiently procure a range of...
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) to Otsuka America Pharmaceutical Inc., a large pharmaceutical manufacturer, for the supply of the drug Jynarque (tolvaptan). The contract has a ceiling value of $91,461.92 and a period of performance through July 31, 2022. The contract was awarded under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), indicating Otsuka's established capability to provide pharmaceutical products to the...
This is a firm-fixed price delivery order awarded by the Department of Veterans Affairs (VA) to Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer, for the provision of the medication Jynarque (tolvaptan). The $24,791.27 contract supports the VA's Veterans Health Administration (VHA) and its integrated service networks across multiple states. Otsuka holds several indefinite delivery vehicles (IDVs) with the VA, including a $396 million Federal Supply Schedule (FSS)...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a delivery order to Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer, to provide the drug Jynarque (tolvaptan) 45mg/15mg. The order, which has a firm-fixed price of $12,580.72 and a completion date of May 8, 2024, was awarded on April 8, 2024 under Otsuka's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). This order is part of a larger $15 million blanket...